MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
Intravenous amphotericin B is a key component of the antifungal therapy for cryptococcal meningitis recommended in South African and international guidelines. Unfortunately, its use is associated with significant toxicity including deterioration in renal function, electrolyte disturbance, anaemia an...
Saved in:
Main Authors: | J Scriven (Author), J Cirota (Author), C Viljoen (Author), M Black (Author), G Meintjes (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2013-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MONITORING AMPHOTERICIN B AND FLUCONAZOLE CONCENTRATIONS IN THE PLASMA AND CEREBROSPINAL FLUID OF PATIENTS WITH CRYPTOCOCCAL MENINGITIS
by: Sílvia Regina Cavani Jorge Santos, et al.
Published: (2012) -
Monitoring Amphotericin B and Fluconazole Concentrations in the Plasma and Cerebrospinal Fluid of Patients with Cryptococcal Meningitis
by: Sílvia Regina Cavani Jorge Santos, et al.
Published: (2012) -
Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa.
by: Susan Meiring, et al.
Published: (2016) -
Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis
by: Elizabeth C. Okafor, et al.
Published: (2020) -
Cryptococcal meningitis in a diabetic
by: Jyoti Prakash, et al.
Published: (2024)